These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27077843)

  • 1. GL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling Pathways.
    Zhang J; Zhang HY; Wang J; You LH; Zhou RZ; Zhao DM; Cheng MS; Li F
    Int J Mol Sci; 2016 Apr; 17(4):470. PubMed ID: 27077843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
    Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
    Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-β-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.
    Guo B; Li X; Song S; Chen M; Cheng M; Zhao D; Li F
    Oncol Rep; 2016 Apr; 35(4):2246-56. PubMed ID: 26821251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.
    Zhou Y; Zhang J; Wang J; Cheng MS; Zhao DM; Li F
    Anat Rec (Hoboken); 2019 Sep; 302(9):1571-1579. PubMed ID: 30773850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
    Zhang HY; Zhang J; Hao CZ; Zhou Y; Wang J; Cheng MS; Zhao DM; Li F
    Am J Transl Res; 2017; 9(6):2736-2747. PubMed ID: 28670365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis.
    Guo Q; Su N; Zhang J; Li X; Miao Z; Wang G; Cheng M; Xu H; Cao L; Li F
    Oncogene; 2014 Jun; 33(25):3277-87. PubMed ID: 23893240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.
    Li X; Li J; Li F
    Oncol Rep; 2017 May; 37(5):2857-2864. PubMed ID: 28393218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the evaluation of their anti-cancer activity.
    Song PL; Wang G; Su Y; Wang HX; Wang J; Li F; Cheng MS
    Bioorg Chem; 2019 Oct; 91():103168. PubMed ID: 31400553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
    Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
    Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.
    Li SQ; Wang ZH; Mi XG; Liu L; Tan Y
    IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
    Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
    Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.
    Song S; Li X; Guo J; Hao C; Feng Y; Guo B; Liu T; Zhang Q; Zhang Z; Li R; Wang J; Lin B; Li F; Zhao D; Cheng M
    Org Biomol Chem; 2015 Mar; 13(12):3803-18. PubMed ID: 25705811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
    J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
    Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
    Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.
    Li D; Zhang Y; Li Z; Wang X; Qu X; Liu Y
    Tumour Biol; 2015 Dec; 36(12):9431-6. PubMed ID: 26124003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion.
    Hao C; Li X; Song S; Guo B; Guo J; Zhang J; Zhang Q; Huang W; Wang J; Lin B; Cheng M; Li F; Zhao D
    Org Biomol Chem; 2016 Aug; 14(32):7676-90. PubMed ID: 27454186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
    Guo B; Zhang T; Su J; Wang K; Li X
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):353-63. PubMed ID: 25527205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.